InvestorsHub Logo
icon url

trading.jeff

02/04/20 6:04 PM

#47655 RE: 5TREE #47654

Yeah, Alpha "messed up," or, in other words, sat on their hands thinking no one else would come along and they had all the time in the world. Now, they want to have a majority of seats on the BOD so they can dictate OncoSec's future to suit their own agenda (whatever that might be). CGP doesn't want a majority of seats, so they aren't looking to dictate OncoSec's future.

If Alpha has all this money, $39M to offer OncoSec, where was it before CGP came on the scene?

$ONCS
icon url

Spicknspan

02/11/20 4:12 PM

#47702 RE: 5TREE #47654

Encouraging data. But just like any negative cash flow biotech, the key is continue to operate until market approval--and capital raising continues too.

With the capital raises comes dilution.